{"text": ["IMBRUVICA\u00ae", "(ibrutinib)", "Data", "in", "Chronic", "Lymphocytic", "Leukemia", "(CLL)", "Show", "up", "to", "Seven", "Years", "of", "Progression-free", "Survival", "(PFS)", "in", "80", "Percent", "of", "Previously", "Untreated", "Patients,", "the", "Longest", "Follow-up", "for", "a", "Bruton's", "Tyrosine", "Kinase", "Inhibitor", "to", "Date"], "created_at": "2018-12-02 17:00:00"}
{"text": ["Why", "Is", "AbbVie", "(ABBV)", "Up", "17.5%", "Since", "Last", "Earnings", "Report?"], "created_at": "2018-12-02 16:08:37"}
{"text": ["Why", "Is", "AbbVie", "(ABBV)", "Up", "17.5%", "Since", "Last", "Earnings", "Report?"], "created_at": "2018-12-02 16:08:37"}
{"text": ["Why", "Is", "AbbVie", "(ABBV)", "Up", "17.5%", "Since", "Last", "Earnings", "Report?"], "created_at": "2018-12-02 14:30:02"}
